Somatostatin induces striatal dopamine release and contralateral turning behaviour in the mouse

Neuroscience Letters

Volumn 358, Issue 2, 2004, Pages 127-131

  Hathway, G J ^a,b   Humphrey, P P A ^b,c   Kendrick, K M ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dopamine; Glutamate; Hippocampus; Locomotion; Microdialysis; Somatostatin; Striatum

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; DOPAMINE; N METHYL DEXTRO ASPARTIC ACID; PEPTIDE; SOMATOSTATIN;

AMYGDALOID NUCLEUS; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CIRCLING BEHAVIOR; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS STRIATUM; DIALYSIS; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; HIPPOCAMPUS; INFUSION; LOCOMOTION; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CORPUS STRIATUM; DOPAMINE; MALE; MICE; MICE, INBRED C57BL; ROTATION; SOMATOSTATIN;

EID: 1542404586     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.09.056     Document Type: Article

References (20)

1. Allen J., Hathwoy G.J., Kendrick K.M., Wilkinson L.S., Humphrey P.P.A., Emson P.C. Somatostatin receptor 2 regulates motoric and anxiolytic effects in murine CNS. Eur. J. Neurosci. 17:2003;1881-1895.
2. Buckmaster P.S., Otero-Corchan V., Rubenstein M., Low M.J. Heightened seizure severity in somatostatin knockout mice. Epilepsy Res. 48:(1-2):2002;43-56.
3. Cheselet M.F., Reisine T.D. Somatostatin regulates dopaminergic release in striatal slices and caudate nuclei. J. Neurosci. 3:1983;232-236.
4. Costall B., Kelly M.E., Naylor R.J. The production of asymmetry and circling behavior following unilateral, intrastriatal administration of neuroleptic agents: A comparison of abilities to antagonize striatal function. Eur. J. Pharmacol. 96:1983;79-86.
5. Costall B., Kelly M.E., Naylor R.J. Unilateral striatal dopamine denervation: Reduced motor inhibitory effects of dopamine antagonists revealed in models of asymmetric and circling behavior. Naunyn Schmiedebergs Arch. Pharmacol. 366:1984;29-35.
6. Eve D.J., Nisbet A.P., Kingsbury A.E., Temlett J., Marsden C.D., Foster O.J. Selective increase in somatostatin mRNA expression in human basal ganglia in Parkinson's disease. Mol. Brain Res. 50:(1-2):1997;59-70.
7. Franklin K., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1998;Academic Press, San Diego, CA.
8. Hathway G.J., Emson P.C., Humphrey P.P.A., Kendrick K.M. Somatostatin potently stimulates in vivo striatal dopamine and γ-aminobutyric acid release by a glutamate dependent action. J. Neurochem. 70:1998;1740-1749.
9. 2 receptors mediate striatal dopamine release. Br. J. Pharmacol. 128:1999;1346-1352.
10. Joyce J.N., Davis R.E., Van Hartesveldt C. Behavioral effects of unilateral dopamine injection into dorsal or ventral striatum. Eur. J. Pharmacol. 87:1983;283-289.
11. Kamegai J., Minami S., Sugihara H., Wakabayashi I. Barrel rotation evoked by intracerebroventricular injection of somatostatin and arginine-vasopressin is accompanied by the induction of c-fos gene expression in the granule cells of rat cerebellum. Mol. Brain Res. 18:(1-2):1993;115-120.
12. Kendrick K.M., Guevara-Guzman R., de la Riva C., Christensen J., Østergaard K., Emson P.C. NMDA and kainite evoked release of nitric oxide and transmitters in the rat striatum: in vivo evidence that nitric oxide may play a neuroprotective role. Eur. J. Neurosci. 8:1996;2619-2634.
13. Koenig J.A., Edwardson J., Humphrey P.P.A. somatostatin receptors in Neuro2A neuroblastoma cells: ligand internalization. Br. J. Pharmacol. 120:1997;52-59.
14. Marti M., Bregola G., Marari M., Gemignani A., Simonato M. Somatostatin release in the hippocampus in the kindling model of epilepsy: a microdialysis study. J. Neurochem. 74:(6):2000;2497-2503.
15. McKenzie J.S., Shafton A.P., Stewart C.A. Intrastriatal dopaminergic agents, muscarinic stimulation and GABA antagonism compared for rotation response in rats. Behav. Brain Res. 45:1991;163-170.
16. Metz G.A., Whishaw I.Q. Drug induced rotation in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance. Neuroscience. 111:(2):2002;325-336.
17. 2 receptor subtypes: a confocal microscopic study using novel fluorescent somatostatin derivatives. Endocrinology. 138:1997;296-306.
18. Thermos K., Radke J.M., Kastellakis A., Anagnostakis Y., Spyraki C. Dopamine-somatostatin interactions in the rat striatum: an in vivo microdialysis study. Synapse. 22:1996;209-216.
19. Ungerstedt U. 6-Hydroxydopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol. 5:1968;107-110.
20. Vacsei L., Pavo I., Zsigo J., Penko B., Widerlov E. Comparative studies of somatostatin-14 and some of its fragments on passive avoidance behavior, open field activity and on barrel rotation phenomenon in rats. Peptides. 10:(6):1989;1153-1157.